title: [Rimonabant--a panacea for patients with metabolic syndrome?].
authors.affiliation: Klinika Chorób Wewnetrznych z Oddzialem Farmakologii Klinicznej i Terapii Monitorowanej Uniwersytetu Medycznego w Lodzi.
authors.forename: Marlena
authors.initials: M
authors.lastname: Broncel
authors.forename: Marzena
authors.initials: M
authors.lastname: Koziróg
mesh_terms: D019440:Anti-Obesity Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D063387:Cannabinoid Receptor Antagonists; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant; D016896:Treatment Outcome
chemical_list: D019440:Anti-Obesity Agents; D001786:Blood Glucose; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant